Bentham Science Logo

Track Your Manuscript:


Current Signal Transduction Therapy

Volume 15, 3 Issues, 2020
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access

Contents

Current Signal Transduction Therapy, Volume 4 - Number 3


Hypoxia Inducible Factor-1 as a Therapeutic Target in Cerebral Ischemia

, 4(3): 162 - 173

Penelope Aguilera, Edgar Vazquez-Contreras, Carlos Daniel Gomez-Martínez and Maria Elena Chanez Cardenas


DOI: 10.2174/157436209789057458





The Inhibitory Effect of Cyclosporine A and Prednisolone on Both Cytotoxic CD8+ T Cells and CD4+CD25+ Regulatory T Cells

, 4(3): 222 - 233

Fei Fei, Yingzhe Yu, Anita Schmitt, Markus Thomas Rojewski, Baoan Chen, Marlies Gotz, Philippe Guillaume, Donald Bunjes and Michael Schmitt


DOI: 10.2174/157436209789057502



Editor-in-Chief

Jingxuan Yang
The University of Oklahoma Health Science Center
Oklahoma City, OK
(USA)
Biography
View Full Editorial Board

COPE Compliant

Journal History

Current Signal Transduction Therapy was launched in 2006. Dr. Jingxuan Yang serves as the Editor-in-Chief of the journal.

Advertisement

Covid Resource Center

Related Journals

Related eBooks

eBooks Catalog